LGT Fund Management Co Ltd. Cuts Stake in Danaher Corporation $DHR

LGT Fund Management Co Ltd. lowered its position in shares of Danaher Corporation (NYSE:DHR) by 9.9% in the second quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 9,530 shares of the conglomerate’s stock after selling 1,050 shares during the quarter. LGT Fund Management Co Ltd.’s holdings in Danaher were worth $1,883,000 as of its most recent filing with the SEC.

Other large investors have also made changes to their positions in the company. GHP Investment Advisors Inc. increased its holdings in shares of Danaher by 396.0% in the 1st quarter. GHP Investment Advisors Inc. now owns 124 shares of the conglomerate’s stock valued at $25,000 after purchasing an additional 99 shares in the last quarter. Sierra Ocean LLC increased its holdings in shares of Danaher by 116.9% in the 1st quarter. Sierra Ocean LLC now owns 141 shares of the conglomerate’s stock valued at $29,000 after purchasing an additional 76 shares in the last quarter. Smallwood Wealth Investment Management LLC purchased a new position in shares of Danaher in the 1st quarter valued at about $31,000. Dunhill Financial LLC increased its holdings in shares of Danaher by 68.4% in the 1st quarter. Dunhill Financial LLC now owns 165 shares of the conglomerate’s stock valued at $34,000 after purchasing an additional 67 shares in the last quarter. Finally, Costello Asset Management INC purchased a new position in shares of Danaher in the 1st quarter valued at about $41,000. Hedge funds and other institutional investors own 79.05% of the company’s stock.

Insider Activity

In other Danaher news, Director Teri List sold 2,778 shares of the firm’s stock in a transaction dated Friday, August 22nd. The shares were sold at an average price of $211.06, for a total transaction of $586,324.68. Following the sale, the director directly owned 20,751 shares of the company’s stock, valued at $4,379,706.06. This trade represents a 11.81% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. 11.10% of the stock is owned by corporate insiders.

Danaher Price Performance

Danaher stock opened at $215.05 on Friday. Danaher Corporation has a 12-month low of $171.00 and a 12-month high of $279.41. The stock has a market capitalization of $153.98 billion, a P/E ratio of 45.75, a P/E/G ratio of 3.06 and a beta of 0.77. The firm’s 50-day moving average is $200.19 and its two-hundred day moving average is $197.33. The company has a debt-to-equity ratio of 0.32, a current ratio of 1.62 and a quick ratio of 1.22.

Danaher (NYSE:DHR) last released its quarterly earnings results on Tuesday, July 22nd. The conglomerate reported $1.80 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.64 by $0.16. Danaher had a net margin of 14.21% and a return on equity of 10.70%. The company had revenue of $5.94 billion for the quarter, compared to analysts’ expectations of $5.83 billion. During the same period last year, the company earned $1.72 EPS. The firm’s revenue for the quarter was up 3.4% compared to the same quarter last year. Danaher has set its FY 2025 guidance at 7.700-7.800 EPS. Equities analysts predict that Danaher Corporation will post 7.63 earnings per share for the current year.

Danaher Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, October 31st. Shareholders of record on Friday, September 26th will be paid a dividend of $0.32 per share. This represents a $1.28 annualized dividend and a dividend yield of 0.6%. The ex-dividend date of this dividend is Friday, September 26th. Danaher’s dividend payout ratio (DPR) is currently 27.23%.

Analysts Set New Price Targets

A number of equities analysts have recently issued reports on DHR shares. Scotiabank upgraded shares of Danaher from a “sector perform” rating to a “sector outperform” rating and set a $275.00 price target for the company in a report on Friday, July 11th. Weiss Ratings reissued a “hold (c-)” rating on shares of Danaher in a research note on Saturday, September 27th. Evercore ISI lowered their price objective on shares of Danaher from $230.00 to $226.00 and set an “outperform” rating on the stock in a research note on Tuesday, July 8th. Robert W. Baird increased their price objective on shares of Danaher from $225.00 to $226.00 and gave the company an “outperform” rating in a research note on Friday, July 18th. Finally, Bank of America lowered their price objective on shares of Danaher from $230.00 to $220.00 and set a “buy” rating on the stock in a research note on Monday, September 22nd. Seventeen investment analysts have rated the stock with a Buy rating and four have given a Hold rating to the stock. According to MarketBeat, the company has an average rating of “Moderate Buy” and an average target price of $245.91.

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.